Showing results (1871-1880 of 1,944) with videos related to

Sort By:
Pageof 195
Gut|April 5, 2020
Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE studyEnrique de-Madaria, Claudia Sánchez-Marin, Irene Carrillo, et al.
Emerging Infectious Diseases|November 20, 2019
Seroprevalence and Risk Factors Possibly Associated with Emerging Zoonotic Vaccinia Virus in a Farming Community, ColombiaAshley Styczynski, Jillybeth Burgado, Diana Walteros, et al.
Cell Reports. Medicine|June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4+CD8+ T cellsAlexander K Tsai, John R Lozada, Philippa R Kennedy, et al.
Environmental Toxicology and Pharmacology|December 13, 2019
Impact of cadmium toxicity on cartilage loss in a 3D in vitro modelZamudio-Cuevas Yessica Eduviges, Gabriela Martínez-Nava, Daniel Reyes-Hinojosa, et al.
Journal of the American Society of Nephrology : JASN|May 31, 2014
Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathyMiguel A Lanaspa, Takuji Ishimoto, Christina Cicerchi, et al.
Biological Reviews of the Cambridge Philosophical Society|July 7, 2020
Movement-mediated community assembly and coexistenceUlrike E Schlägel, Volker Grimm, Niels Blaum, et al.
Clinical Rheumatology|October 6, 2022
The impact of short-chain fatty acid-producing bacteria of the gut microbiota in hyperuricemia and gout diagnosisGabriela A Martínez-Nava, Eder O Méndez-Salazar, Janitzia Vázquez-Mellado, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsJonathan Adrian Zegarra-Valdivia, Milagros Del Rocio Casimiro-Arana, Leandro Aron Perez-Fernandez, et al.
Frontiers in Immunology|June 9, 2025
First-in-human evaluation of a no-alpha interleukin-2 mutein: safety and preliminary pharmacodynamic and clinical effectIraida Caballero Aguirrechu, Braulio Mestre Fernández, Jorge Luis Soriano García, et al.
Archivos De Cardiologia De Mexico|June 29, 2021
Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)Carlos I Ponte-Negretti, Fernando S Wyss, Daniel Piskorz, et al.
Pageof 195